Fractyl Health, Inc. GUTS
We take great care to ensure that the data presented and summarized in this overview for Fractyl Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GUTS
Top Purchases
Top Sells
About GUTS
Insider Transactions at GUTS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2024
|
Bessemer Venture Partners Vii L.P. |
BUY
Conversion of derivative security
|
Indirect |
4,770,901
+50.0%
|
-
|
|
Feb 06
2024
|
Corebridge Deco Ii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
673,391
+50.0%
|
-
|
|
Feb 06
2024
|
American International Group, Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,339,261
+50.0%
|
-
|
|
Feb 06
2024
|
Home Assurance CO American > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
283,878
+50.0%
|
-
|
|
Feb 06
2024
|
Clive Meanwell |
BUY
Conversion of derivative security
|
Indirect |
277,890
+50.0%
|
-
|
|
Feb 06
2024
|
General Catalyst Gp V, LLC |
BUY
Conversion of derivative security
|
Indirect |
4,800,310
+49.57%
|
-
|
|
Feb 06
2024
|
Mithril LP |
BUY
Open market or private purchase
|
Indirect |
333,333
+21.03%
|
$4,999,995
$15.0 P/Share
|
|
Feb 06
2024
|
Mithril LP |
BUY
Conversion of derivative security
|
Indirect |
918,567
+50.0%
|
-
|
|
Feb 06
2024
|
Mithril LP |
BUY
Conversion of derivative security
|
Direct |
5,160,301
+50.0%
|
-
|
|
Feb 06
2024
|
Harith Rajagopalan Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
2,795
+0.95%
|
-
|
|
Feb 06
2024
|
Harith Rajagopalan Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
6,523
+0.97%
|
-
|
|
Feb 06
2024
|
Jay David Caplan President, Chief Product Off. |
BUY
Conversion of derivative security
|
Indirect |
142,109
+28.05%
|
-
|
|
Feb 06
2024
|
Ajay Royan |
BUY
Open market or private purchase
|
Indirect |
333,333
+21.03%
|
$4,999,995
$15.0 P/Share
|
|
Feb 06
2024
|
Ajay Royan |
BUY
Conversion of derivative security
|
Indirect |
6,078,868
+50.0%
|
-
|
|
Feb 06
2024
|
Marc Elia |
BUY
Open market or private purchase
|
Indirect |
466,666
+20.09%
|
$6,999,990
$15.0 P/Share
|
|
Feb 06
2024
|
Marc Elia |
BUY
Conversion of derivative security
|
Indirect |
1,389,451
+50.0%
|
-
|
|
Feb 06
2024
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
834,254
+29.21%
|
-
|
|
Feb 06
2024
|
Cvf, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
333,333
+6.66%
|
$4,999,995
$15.0 P/Share
|
|
Feb 06
2024
|
Cvf, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,340,537
+33.75%
|
-
|
Last 12 Months Summary
Buy / Acquisition
32.5M
Shares
From
17
Insiders
| Conversion of derivative security | 31M shares |
|---|---|
| Open market or private purchase | 1.47M shares |
Sell / Disposition
0
Shares
From
0
Insiders